Champions Oncology (CSBR) Share-based Compensation (QoQ) (2010 - 2026)
Champions Oncology (CSBR) Share-based Compensation (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Champions Oncology | 68.61 Mn | 68.61 Mn | 7.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -15.60% |
| Jan 31, 2026 | 69.88% |
| Oct 31, 2025 | 19.71% |
| Jul 31, 2025 | 58.78% |
| Apr 30, 2025 | -48.83% |
| Jan 31, 2025 | 2,744.44% |
| Oct 31, 2024 | -96.51% |
| Jul 31, 2024 | -1.90% |
| Apr 30, 2024 | -30.61% |
| Jan 31, 2024 | 615.09% |
| Oct 31, 2023 | -87.47% |
| Jul 31, 2023 | 103.37% |
| Apr 30, 2023 | -37.16% |
| Jan 31, 2023 | 178.15% |
| Oct 31, 2022 | -42.23% |
| Jul 31, 2022 | 9.57% |
| Apr 30, 2022 | -39.35% |
| Jan 31, 2022 | 131.34% |
| Oct 31, 2021 | -52.14% |
| Jul 31, 2021 | -87.55% |